{
    "Trade/Device Name(s)": [
        "LIAISON\u00ae Lyme Total Antibody Plus",
        "LIAISON\u00ae Lyme Total Antibody Plus Control Set"
    ],
    "Submitter Information": "DiaSorin Inc.",
    "510(k) Number": "K193051",
    "Predicate Device Reference 510(k) Number(s)": [
        "K113397"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LSR",
        "QCH"
    ],
    "Summary Letter Date": "October 31, 2019",
    "Summary Letter Received Date": "November 1, 2019",
    "Submission Date": "January 11, 2020",
    "Regulation Number(s)": [
        "21 CFR 866.3830"
    ],
    "Regulation Name(s)": [
        "Treponema pallidum treponemal test reagents"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "immunology"
    ],
    "Analyte(s)": [
        "IgG antibodies to Borrelia burgdorferi",
        "IgM antibodies to Borrelia burgdorferi"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma (K2-EDTA)",
        "Plasma (Lithium heparin)",
        "Serum separator tubes (SST)"
    ],
    "Specimen Container(s)": [
        "K2-EDTA tube",
        "Lithium heparin tube",
        "Serum separator tube (SST)"
    ],
    "Instrument(s)/Platform(s)": [
        "LIAISON\u00ae XL Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Indirect chemiluminescent immunoassay (CLIA)"
    ],
    "Methodologies": [
        "Immunoassay",
        "Chemiluminescence"
    ],
    "Submission Type(s)": [
        "Assay",
        "Control Set"
    ],
    "Document Summary": "FDA 510(k) summary for LIAISON\u00ae Lyme Total Antibody Plus assay and control set for qualitative detection of IgG/IgM antibodies to Borrelia burgdorferi using chemiluminescent immunoassay on the LIAISON\u00ae XL Analyzer",
    "Indications for Use Summary": "Qualitative determination of IgG and IgM antibodies to Borrelia burgdorferi in human serum and plasma from patients with signs and symptoms consistent with Lyme disease; positive or equivocal results require supplemental Western blot testing to support clinical diagnosis",
    "fda_folder": "Microbiology"
}